Answers are grounded in this paper and cite their sources.
Assessment shows BoNT-A therapy improves health-related quality of life in chronic migraine patients, suggesting effective management.
Our findings suggest that BoNT-A therapy can improve HRQol by reducing the incidence of migraine headaches. Thus, BoNT-A can be effective in the management of CM.
No takes yet. Share an insight, caveat, or question.
Barkataky et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: